**Question:** Antigen involved in post transplant rejection -

A. Human Leukocyte Antigen (HLA)
B. Cytomegalovirus (CMV)
C. Epstein-Barr virus (EBV)
D. Hepatitis B virus (HBV)

**Core Concept:** Post-transplant rejection is a response from the recipient's immune system against the foreign antigens of the transplanted organ, potentially leading to organ damage or failure. Antigens are molecules on the surface of cells and play a crucial role in immune response. In the context of organ transplantation, the major antigens involved are Human Leukocyte Antigens (HLA).

**Why the Correct Answer is Right:**

HLA, short for Human Leukocyte Antigen, is a group of molecules encoded by the HLA genes. These molecules are expressed on the surface of cells and play a vital role in immune response. In the context of organ transplantation, HLA antigens are responsible for the immune system recognizing the transplanted organ as foreign and triggering an immune response. This leads to post-transplant rejection and potential organ damage or failure.

**Why Each Wrong Option is Incorrect:**

- Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are viral pathogens that can cause infections in transplant recipients. While they are important considerations in transplant medicine, they are not the primary antigens responsible for post-transplant rejection. CMV and EBV infections can exacerbate the immune response against the transplanted organ, but they are not the antigens triggering the immune response directly.

- Hepatitis B virus (HBV) is a viral pathogen causing liver infections. Like CMV and EBV, HBV can impact transplant recipients but is not the primary antigen involved in post-transplant rejection.

**Clinical Pearl:**

Understanding the role of HLA antigens in post-transplant rejection is crucial for transplant physicians to manage immunosuppressive therapy effectively. The primary focus in organ transplantation is to prevent both acute and chronic rejection while minimizing the risk of infections and malignancies due to immunosuppressive therapy.

To achieve this balance, physicians monitor HLA typing of donor and recipient, ensuring a good HLA match. Additionally, they prescribe immunosuppressive therapy based on the risk of rejection and complications. This approach helps minimize the immune response that could lead to organ dysfunction or failure due to HLA antigens acting as foreign foreign substances.